2026
Temporal Trends in the Burden of Drug Use Disorders in East and Southeast Asian Countries And Territories from 1990 to 2021: Findings from the Global Burden of Disease Study 2021
The authors analysed temporal trends in incidence, prevalence, and disability-adjusted life years (DALYs) of DUDs by drug categories at regional and national levels in East and South-East Asia. Additionally, the authors calculated the estimated annual percentage change (EAPC) of incidence and prevalence and employed age-period-cohort (APC) modelling to estimate the independent effects of age, period, and cohort.
2025
From 1990 to 2035: The Evolving Burden of Mental Disorders, Substance Use, and Self-harm in Young People Across Asia
The study is a secondary analysis of data from the Global Burden of Disease (GBD) 2021 study, a publicly available repository of comprehensive global health estimates maintained by the Institute for Health Metrics and Evaluation (IHME). The authors analyzed prevalence, incidence, and disability-adjusted life years. Trends were assessed using average annual percent change, while a Bayesian age-period-cohort model projected future prevalence. Correlations with the Socio-demographic Index (SDI) were also examined.
2025
Methamphetamine in Central Asia
The study is a report conducted in the framework of the Central Asian Drug Action Programme (CADAP). The study analyses the trafficking and consumption of methamphetamine in Central Asia. Traditionally situated on the Northern route of opioid trafficking from neighbouring Afghanistan to Russia and Europe, Central Asia has witnessed an increase in the spread of synthetic drugs in recent years, including methamphetamine, which are new to the region.
2025
A Study Into the HIV/AIDS Knowledge of Social Workers and Social Work Students in Kyrgyzstan and Their Attitudes Towards People Living with HIV
Aisuluu Shailoobek kyzy,
Ulla Pape,
Nurgul Musaeva,
Zhyldyz Asekova,
Ingo lIja Michels
The level of HIV awareness among social workers in Kyrgyzstan is still low, which negatively impacts on the quality of the services they provide. The study examines the knowledge of social workers an...
2025
Motives for New Psychoactive Substances Consumption Among Young Adults in Uzbekistan: A Qualitative Study Protocol
Guzalkhon Zakhidova,
Vladimir Pikirenia,
Timur Syunyakov,
Maria Prilutskaya
New psychoactive substances (NPS) represent a global problem, especially among young people. In Central Asia, while the trafficking in NPS continues to grow, there remains a lack of data on the socia...
2025
Protocol of Collaboration Between Prison Staff and Civil Society Regarding People Who Use Drugs in Prison
This document presents the Protocol of Collaboration between prison staff and civil society regarding people who use drugs in prison.
2025
Breaking the Silence: Confronting Stigma and Substance Use Disorder
Hang Su
In a world where the complexities of human experience are often oversimplified, the intertwined issues of stigma and substance use disorder (SUD) demand a more nuanced exploration. Stigma, a pervasiv...
2025
NGO Involvement in Drug Treatment and Infectious Disease Prevention in Central Asia and China
Jarkyn Shadymanova
This anthology examines the role of NGOs in the treatment of drug addiction and the prevention of infectious diseases such as HIV, hepatitis and tuberculosis in Central Asia and China. Innovative met...
2025
Invisible and Ignored: Women and Drugs in Central Asia
Katarzyna Kinga Kowalczyk,
Larissa Steimle,
Meryem Grabski
The book sheds light on the often invisible realities of women who use drugs or live with HIV in Central Asia. These realities and the resulting needs are frequently overlooked or ignored in both aca...
2025
New Psychoactive Substances: Studies from Central Asia and China
Mariya Prilutskaya
The rise of new psychoactive substances (NPS) is a major challenge in drug policy, as these substances evade legal controls and spread quickly. This volume explores the NPS crisis in Central Asia and...